Tackling issues of in vitro diagnostics for personalized medicine, - PowerPoint PPT Presentation

Mar 11, 2024 •248 likes •322 views

MOLECULAR PATHOLOGY WG BIOBANKING AND MOLECULAR PATHOBIOLOGY WG Tackling issues of in vitro diagnostics for personalized medicine, SPIDIA4P EUROPEAN PARLIAMENT, 5TH MARCH 2019 Giorgio Stanta Trieste University European Commission Initiative

MOLECULAR PATHOLOGY WG BIOBANKING AND MOLECULAR PATHOBIOLOGY WG Tackling issues of in vitro diagnostics for personalized medicine, SPIDIA4P EUROPEAN PARLIAMENT, 5TH MARCH 2019 Giorgio Stanta Trieste University
European Commission Initiative on Breast Cancer (ECIBC) (Quality Assurance Development Scheme Group) 1. Screening 4. Rehabilitation Screening Complications positive 2. 6. Palliative Recurrent Diagnostic 3. Treatment 5. Follow-up care disease Procedures Symptoms No complications Quality Potential at interface of CLINICAL 2 ° level of processes RESEARCH diagnosis- Sub-group Time: Disease free treatment Information: 2 GDG and QASDG kick-off meetings – 7 to 11 September - Ispra
HIST History of pathology AUT Autopsy pathology INFE Infectious diseases pathology BREAST Breast pathology CARD IT IT in pathology Cardiovascular pathology MOPA Molecular pathology CYTO Cytopathology NEPH DERM Dermatopathology Nephropathology DEVEL Pathology in favour of NEURO Neuropathology developing countries A better and more OPHTH Ophthalmic pathology DIGE-GI Digestive diseases pathology (GI) reproducible molecular diagnosis EM PAED Paediatric and perinatal pathology Electron microscopy PULM Pulmonary pathology ENDO Endocrine pathology SO-TI GYNAE Gynaecological pathology Soft tissue and bone pathology THYM Thymic and mediastinal pathology HAEMA Haematopathology H & N Head and neck pathology URO Uropathology
Increased reproducibility of molecular analyses to increase exchangeability among institutions. Shorter time to apply the new knowledge to patients.
Main factors defining reproducibility in molecular diagnostics and clinical research -Pre-analytical conditions of biological material (SPIDIA4P > CEN > ISO) -Standardizations (SOPs) of methods > European level projects (NGS) -Heterogeneity of tumours > Standardized sampling and liquid biopsies
eMPAm European Molecular Pathology Master European Molecular Pathology Master – Initial Steering Committee “ Michael Hummel (Germany) Aurelio Ariza Fernandez (Spain) ” Marius Ilie (France) Karl-Friedrich Becker (Germany) Andreas Jung (Germany) Serena Bonin (Italy - Secretary) Annette Lebeau (Germany) Leonor David (Portugal) Henrique Rui (Portugal) Ambrogio Fassina (Italy) Ed Schuuring (Netherlands) Falko Fend (Germany) � Giorgio Stanta (Italy - Chair) Pedro L Fernández (Spain) � � Emmanuelle Uro-Coste (France) Gerald Höfler (Austria) � � �

Recommend

Biobanking: Key to the implementation of standards in personalized medicine Kurt Zatloukal

Biobanking: Key to the implementation of standards in personalized medicine Kurt Zatloukal Diagnostic and Research Center for Molecular Biomedicine, Medical University Graz, Austria Tackling Issues of in vitro Diagnostics Funded by in

1.31k views • 16 slides

Regulation of Digital Health Technologies Adam C. Berger, Ph.D. Office of In Vitro Diagnostics

Regulation of Digital Health Technologies Adam C. Berger, Ph.D. Office of In Vitro Diagnostics and Radiological Health, FDA Personalized Medicine Coalition Policy Committee Meeting April 18, 2018 Digital Health Technologies being used to:

755 views • 40 slides

Companion In Vitro Diagnostics and Oncology Drug Approvals Gregory H. Reaman, M.D. Associate

As Presented at the NCCS Cancer Policy Roundtable October 18-19, 2011 Companion In Vitro Diagnostics and Oncology Drug Approvals Gregory H. Reaman, M.D. Associate Director Office of Hematology Oncology Products Center for Drug Evaluation and

214 views • 6 slides

IMDRF UDI WG UNIQUE DEVICE IDENTIFICATION for medical devices and in vitro diagnostics medical

IMDRF UDI WG UNIQUE DEVICE IDENTIFICATION for medical devices and in vitro diagnostics medical devices Nice, 19 March 2013 Laurent SELLES European Commission - DG Health & Consumers Health and Consumers Presentation to the IMDRF

229 views • 18 slides

Telexos Next Generation Liquid Biopsy for Personalized Cancer Diagnostics - Presentation,

Telexos Next Generation Liquid Biopsy for Personalized Cancer Diagnostics - Presentation, March 2020 Contact: Dr. Erhard Fernholz CEO E-Mail: erhard.fernholz@telexos.de Telexos Overview Telexos/Current Status Area of activity: Cancer

169 views • 15 slides

Standardization and Improvement of Generic Preanalytical Tools and Procedures for In Vitro

Standardization and Improvement of Generic Preanalytical Tools and Procedures for In Vitro Diagnostics - EU Project SPIDIA - 3 rd Annual BRN Symposium Bethesda, March 25 th 2010 Dr. Uwe Oelmueller QIAGEN GmbH (Coordinator) Agenda

569 views • 19 slides

The Intersection of Genomics Research and the IDE Regulation Katherine Donigan, Ph.D. Personalized

The Intersection of Genomics Research and the IDE Regulation Katherine Donigan, Ph.D. Personalized Medicine Staff FDA/CDRH/OIR October 19, 2017 1 www.fda.gov In Vitro Diagnostic (IVD) Regulation Through the 1976 medical device amendments to the

400 views • 22 slides

Tackling Employment and Stimulus Issues During the COVID-19 Pandemic Presented By: Shannon

Tackling Employment and Stimulus Issues During the COVID-19 Pandemic Presented By: Shannon Cohorst Johnson John Vering John Fuchs *This webinar will be recorded and made available after the seminar to attendees and others unable to attend

709 views • 55 slides

JOINT DEGREE MANAGEMENT AND ADMINISTRATION NETWORK TACKLING CURRENT ISSUES AND FACING FUTURE

JOINT DEGREE MANAGEMENT AND ADMINISTRATION NETWORK TACKLING CURRENT ISSUES AND FACING FUTURE CHALLENGES National Legislation Regarding Tuition Fees of Master Programmes within the EU The following table is based on

317 views • 10 slides

DEFINITION OF PERSONALIZED LEARNING Personalized learning is a

6/16/15 SESSION 4: CULTIVATING PERSONALIZED LEARNING THROUGH HABITS OF MIND Bena Kallick & Allison Zmuda June 3, 2015 DEFINITION OF PERSONALIZED

304 views • 7 slides

FOR LIVE PROGRAM ONLY Tax Reporting Mechanics of Trust Decanting: Tackling Compliance Issues in

FOR LIVE PROGRAM ONLY Tax Reporting Mechanics of Trust Decanting: Tackling Compliance Issues in the Absence of IRS Guidance MONDAY, NOVEMBER 21, 2016, 1:00-2:50 pm Eastern IMPORTANT INFORMATION FOR THE LIVE PROGRAM This program is approved for 2

514 views • 34 slides

Personalized Genomics of Cancer 02-223 Personalized Medicine:

Personalized Genomics of Cancer 02-223 Personalized Medicine: Understanding Your Own Genome Fall 2014 Acknowledgement: Dr. Russell Schwarts for slides

593 views • 41 slides

Bioaccessibility studies using in vitro extraction methods on soils vitro extraction methods on

Bioaccessibility studies using in vitro extraction methods on soils vitro extraction methods on soils of North America Suzette A. Morman, RN, MSc., MPH smorman@usgs.gov (303) 236-1205 David B. Smith, PhD gplumlee@usgs.gov (303) 236-1204 U.S.

863 views • 20 slides

Personal Genomes and Social/Ethical/ Legal Issues 02-223 Personalized Medicine:

Personal Genomes and Social/Ethical/ Legal Issues 02-223 Personalized Medicine: Understanding Your Own Genome Fall 2014 Declining Cost of Genome Sequencing The genome sequencing is

441 views • 42 slides

"Dynamic in-vitro organ models of metabolism" Arti Ahluwalia Multi Dimensional in vitro

"Dynamic in-vitro organ models of metabolism" Arti Ahluwalia Multi Dimensional in vitro Models Group Centro di Ricerca E.Piaggio University of Pisa 100 years on, whats missing? 1. Cells do not live on 2D plates. 2.

1.04k views • 25 slides

Personalized Learning October 2018 Pattonville Personalized Learning Vision Students own their

Personalized Learning October 2018 Pattonville Personalized Learning Vision Students own their learning, unconstrained by time, practice, or structure, to meet their unique learning goals supporting their future success. Personalized

414 views • 7 slides

Diagnostics: A focus on use in development of drugs for MDR pathogens John H. Rex, MD

Diagnostics: A focus on use in development of drugs for MDR pathogens John H. Rex, MD AstraZeneca Pharmaceuticals Rex - Diagnostics, EMA workshop 25-26 Oct 2012 1 Key ideas in advance New diagnostics are hard work Speed &

260 views • 14 slides

In Vitro Lecture and Luncheon Sponsored ed by the C e Colgate P e Palmolive C e Company More

In Vitro Lecture and Luncheon Sponsored ed by the C e Colgate P e Palmolive C e Company More Than Skin Deep: When Alternative Approaches Outperform Animal Tests 2018 In Vitro Lecture Nicole Kleinstreuer Speaker Schedule 11:30 AM12:00

295 views • 26 slides

Personalized Learning Environments Architectural Considerations for Supporting Personalized

Personalized Learning Environments Architectural Considerations for Supporting Personalized Learning Primor ordial M l Metaphor hors f for Learning Types of Interaction, Instruction, Study Watering Hole Mountain Top Sandpit Cave

310 views • 30 slides

Stock Basis Calculation for Pass-Through Entities: Challenges for Tax Professionals Tackling

Stock Basis Calculation for Pass-Through Entities: Challenges for Tax Professionals Tackling Complex Issues for S Corporations, LLCs and Partnerships TUESDAY, AUGUST 6, 2013, 1:00-2:50 pm Eastern IMPORTANT INFORMATION This program is approved

1.34k views • 75 slides

Basis Calculations for Pass-Through Entities: Challenges for Tax Preparers Tackling Complex

Basis Calculations for Pass-Through Entities: Challenges for Tax Preparers Tackling Complex Calculation Issues for S Corporations, Partnerships and LLCs TUESDAY, JANUARY 8, 2013, 1:00-2:50 pm Eastern IMPORTANT INFORMATION This program is

1.04k views • 85 slides

Nonintercepting ODR Diagnostics for Multi-GeV Electron Beams Alex H. Lumpkin ASD Diagnostics

Nonintercepting ODR Diagnostics for Multi-GeV Electron Beams Alex H. Lumpkin ASD Diagnostics Group Advanced Photon Source Jefferson Lab CASA Seminar September 28, 2006 OUTLINE Introduction Overview of the APS Nonintercepting (NI)

1.13k views • 47 slides

Ion source diagnostics and ion beam diagnostics for ECRIS intensity profile emittance

Ion source diagnostics and ion beam diagnostics for ECRIS intensity profile emittance space charge compensation light/X-rays coming from plasma 11/18/2014 1 Intensity measurements Load on extraction PS Faraday

141 views • 11 slides

ASC 740 Income Tax Accounting Challenges in 2013 Tackling Valuations of Deferred Tax Assets, Tax

Presenting a live 110-minute teleconference with interactive Q&A ASC 740 Income Tax Accounting Challenges in 2013 Tackling Valuations of Deferred Tax Assets, Tax Expense and UTP Reporting, and Other Issues TUESDAY, MAY 28, 2013 1pm Eastern

1.34k views • 96 slides